Geron
GERN
#6280
Rank
C$1.15 B
Marketcap
C$1.81
Share price
3.15%
Change (1 day)
-67.57%
Change (1 year)

Geron (GERN) - Cash on Hand

Cash on Hand as of September 2025 : C$0.52 Billion

According to Geron's latest financial reports the company has C$0.52 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Geron - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31C$0.58 B31.81%
2023-12-31C$0.44 B88.82%
2022-12-31C$0.23 B0.11%
2021-12-31C$0.23 B-6.44%
2020-12-31C$0.25 B37.53%
2019-12-31C$0.18 B-18.19%
2018-12-31C$0.22 B86.85%
2017-12-31C$0.11 B-22.87%
2016-12-31C$0.15 B-2.21%
2015-12-31C$0.15 B-10.2%
2014-12-31C$0.17 B153.12%
2013-12-31C$69.43 M-26.91%
2012-12-31C$95 M-23.01%
2011-12-31C$0.12 B-33.83%
2010-12-31C$0.18 B58.81%
2009-12-31C$0.11 B-40.69%
2008-12-31C$0.19 B-3.66%
2007-12-31C$0.20 B-17.26%
2006-12-31C$0.24 B12%
2005-12-31C$0.22 B53.9%
2004-12-31C$0.14 B1.67%
2003-12-31C$0.14 B90.97%
2002-12-31C$74.21 M-32.43%
2001-12-31C$0.10 B121.98%
2000-12-31C$49.47 M-12.71%
1999-12-31C$56.68 M124.79%
1998-12-31C$25.21 M330.43%
1997-12-31C$5.85 M-65.51%
1996-12-31C$16.98 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Eterna Therapeutics
ERNA
C$4.2 M-99.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$10.15 B 1,831.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
C$0.20 B-61.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
C$4.04 B 669.93%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
C$81.52 M-84.49%๐Ÿ‡บ๐Ÿ‡ธ USA